Resmed Inc. buy Citigroup Inc.
Start price
18.09.25
/
50%
€229.80
Target price
18.09.26
€279.41
Performance (%)
-26.00%
Price
05.06.26
€170.05
Summary
This prediction is currently active. The prediction for Resmed Inc. disappoints with a performance of -26.00%. This prediction currently runs until 18.09.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 4.038% | 4.038% |
| iShares Core DAX® | -1.862% | 0.670% |
| iShares Nasdaq 100 | -3.322% | 4.989% |
| iShares Nikkei 225® | -2.299% | 6.129% |
| iShares S&P 500 | -1.313% | 3.399% |
Comments by Citigroup_Inc_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $330.00 price target on the stock.
Ratings data for RMD provided by MarketBeat